AbbVie (ABBV) Other Non Operating Income (2012 - 2026)

AbbVie has disclosed Other Non Operating Income across 15 years of filings, most recently posting -$2.3 billion for Q1 2026.

• In Q1 2026, Other Non Operating Income fell 59.58% year-over-year to -$2.3 billion; the TTM figure through Mar 2026 stood at -$11.2 billion (down 1172.05% YoY), while the FY2025 annual figure was -$5.8 billion, down 27485.71% from the prior year.
• Other Non Operating Income grew to -$2.3 billion in Q1 2026, from -$5.7 billion in the prior quarter.
• Over the last five years, Other Non Operating Income for ABBV reached as high as $3.1 billion in Q4 2024 and fell as low as -$5.7 billion in Q4 2025.
• The 5-year median for Other Non Operating Income is -$586.0 million (2024), against an average of -$1.0 billion.
• Annual changes were most pronounced in 2022 — Other Non Operating Income surged 8722.22% — and 2023, when it plunged 2904.26%.
• A 5-year view of Other Non Operating Income shows it stood at $279.0 million in 2022, then tumbled by 1741.58% to -$4.6 billion in 2023, then jumped by 167.01% to $3.1 billion in 2024, then tumbled by 287.23% to -$5.7 billion in 2025, then jumped by 59.87% to -$2.3 billion in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered -$2.3 billion, -$5.7 billion, and -$503.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.